Literature DB >> 25610265

Senior-loken syndrome with rare manifestations: a case report.

Harikrishan K Aggarwal1, Deepak Jain1, Sachin Yadav1, Vipin Kaverappa1, Abhishek Gupta1.   

Abstract

Senior-Loken syndrome refers to a disorder in which there is a combination of nephronophthisis and retinal dystrophy. The earliest presenting signs of the renal component are polyuria and polydipsia secondary to defective urinary concentrating ability. Nephronophthisis progresses to end-stage renal disease during the second decade. The retinal lesions are variable, ranging from severe infantile onset retinal dystrophy to more typical retinitis pigmentosa. There is a spectrum of other associated features, including skeletal, dermatological and cerebellar anomalies, observed in this entity. Here, we report a case of Senior-Loken syndrome associated with small hand (short metacarpals) and madarosis. To date, there are no cases reported in the literature describing the association of madarosis with this syndrome, and the presence of small hands has been reported only once.

Entities:  

Keywords:  Madarosis; Senior-Loken syndrome; nephronophthisis; retinitis pigmentosa; small hands

Year:  2013        PMID: 25610265      PMCID: PMC4261493          DOI: 10.5152/eajm.2013.25

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  10 in total

1.  Senior-Loken syndrome with unusual manifestations.

Authors:  N P Singh; S Anuradha; S Gupta; S N Rizvi; R Arora
Journal:  J Assoc Physicians India       Date:  1998-08

2.  Juvenile familial nephropathy with tapetoretinal degeneration. A new oculorenal dystrophy.

Authors:  B SENIOR; A I FRIEDMANN; J L BRAUDO
Journal:  Am J Ophthalmol       Date:  1961-11       Impact factor: 5.258

3.  Hereditary renal dysplasia and blindness.

Authors:  A C LOKEN; O HANSSEN; S HALVORSEN; N J JOLSTER
Journal:  Acta Paediatr       Date:  1961-03       Impact factor: 2.299

4.  The nephronophthisis complex. A clinicopathologic study in children.

Authors:  R Waldherr; T Lennert; H P Weber; H J Födisch; K Schärer
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1982

5.  Sector retinitis pigmentosa in juvenile nephronophthisis.

Authors:  V Godel; A Iaina; P Nemet; M Lazar
Journal:  Br J Ophthalmol       Date:  1980-02       Impact factor: 4.638

6.  Senior-Loken syndrome (nephronophthisis and tapeto-retinal degeneration): a study of 8 cases from 5 families.

Authors:  J P Fillastre; J Guenel; P Riberi; P Marx; J A Whitworth; J M Kunh
Journal:  Clin Nephrol       Date:  1976-01       Impact factor: 0.975

7.  Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.

Authors:  Vincent H Gattone; Xiaofang Wang; Peter C Harris; Vicente E Torres
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

8.  Hypomorphic mutations in meckelin (MKS3/TMEM67) cause nephronophthisis with liver fibrosis (NPHP11).

Authors:  E A Otto; K Tory; M Attanasio; W Zhou; M Chaki; Y Paruchuri; E L Wise; M T F Wolf; B Utsch; C Becker; G Nürnberg; P Nürnberg; A Nayir; S Saunier; C Antignac; F Hildebrandt
Journal:  J Med Genet       Date:  2009-06-08       Impact factor: 6.318

9.  Ultrasound findings in juvenile nephronophthisis.

Authors:  D L Blowey; U Querfeld; D Geary; B A Warady; U Alon
Journal:  Pediatr Nephrol       Date:  1996-02       Impact factor: 3.714

Review 10.  Nephronophthisis.

Authors:  Rémi Salomon; Sophie Saunier; Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2008-07-08       Impact factor: 3.714

  10 in total
  3 in total

1.  Senior- loken syndrome - a ciliopathy.

Authors:  Hemachandar R
Journal:  J Clin Diagn Res       Date:  2014-11-20

2.  Senior Loken Syndrome.

Authors:  Amarpreet Kaur; Shashi Kant Dhir; Geetika Goyal; Naveen Mittal; R K Goyal
Journal:  J Clin Diagn Res       Date:  2016-11-01

3.  Defective INPP5E distribution in NPHP1-related Senior-Loken syndrome.

Authors:  Ke Ning; Emilie Song; Brent E Sendayen; Philipp P Prosseda; Kun-Che Chang; Alireza Ghaffarieh; Jorge A Alvarado; Biao Wang; Kathryn M Haider; Nicolas F Berbari; Yang Hu; Yang Sun
Journal:  Mol Genet Genomic Med       Date:  2020-12-11       Impact factor: 2.473

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.